FOLDNEUTRAL

Gross Margin

85.7%

Higher than 88% of Healthcare sector peers

Updated 94h ago

Sector Performance

88th percentile

FOLD

85.7%

Sector Median

68.9%

Sector Avg

-20.2%

📊

Deep Analysis

Amicus Therapeutics currently reports a gross margin of 85.7%, meaning it keeps 85.7 cents of every dollar of revenue after deducting the direct costs of producing its drugs.

This is well above the healthcare sector median of 68.9%, placing the company in the 88th percentile among its peers. The year-over-year change is not available, but the quarter-over-quarter change shows a 1.3 percentage point improvement from 84.6% to 85.7% based on the two most recent periods. While the high absolute level signals strong pricing power and efficient production, the limited trend data—only one quarter of sequential increase—makes it difficult to assess the durability of the margin. The combination of an already elevated gross margin with a slight upward move reduces near-term risk of margin compression, but does not on its own signal a compelling opportunity. This metric supports the overall NEUTRAL verdict because the strong gross margin is a positive attribute, yet the lack of a longer trend and other factors likely keep the broader outlook balanced.

Frequently Asked Questions

What does the Gross Margin tell investors about FOLD?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does FOLD's Gross Margin compare to its sector?

FOLD's Gross Margin of 85.7% compares to a Healthcare sector median of 68.9%, placing it in the 88th percentile.

Who are FOLD's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), TDOC (67.8%), TECH (66.9%), NTRA (64.8%), RMD (62.2%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.